Serum Institute of India

Prime Minister Narendra Modi today undertook a three city tour to conduct extensive review of the vaccine development and manufacturing process. He visited the Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad and Serum Institute…

“Our premier institution – the Indian Council of Medical Research (ICMR) - is involved in the trial of COVID-19 vaccines’ executions. India is also hosting clinical trials for all the major vaccine contenders. About 30 vaccines are in…

The clinical trials of Oxford vaccine will continue in India as usual as it has faced no issue at all, the Serum Institute of India (SII) said on Wednesday over the recent report of phase-three study of the Covid-19 vaccine being put on…

India is on course to have an "approved" vaccine within the first quarter of calendar year 2021 and Pune based Serum Institute of India (SII), the world's largest vaccine manufacturer by volume, is well placed to deliver the first vaccine,…

The Post Graduate Institute of Medical Education and Research (PGIMER) in Chandigarh will be beginning the Phase II trial of oxford Covid-19 vaccine candidate -- Covishield from the first week of September.The premier institute has received…

Serum Institute of India, has clarified that the current claims surrounding Covishield's availability in the media are completely false and conjectural."Presently, the government has granted us permission to only manufacture the vaccine and…

Union Minister of Health and Family Welfare Harsh Vardhan said on Saturday that the country will have a vaccine against the deadly coronavirus by the end of the year.Speaking to reporters here, he said that a Covid-19 vaccine is likely in…

Serum Institute of India (SII), the worlds largest vaccine manufacturer by volume, has entered into a new landmark partnership with Gavi, The Vaccine Alliance and the Bill & Melinda Gates Foundation, to accelerate the manufacture and…

The Serum Institute of India (SII) will launch the first Covid-19 vaccine called 'Covishield' and commence its trials soon in India.SII released a representative image of the vial of Covishield which is the vaccine developed by the Oxford…

The Serum Institute of India (SII) will soon apply to the Indian regulator for the licensure trials of the AstraZeneca-Oxford Covid vaccine.Commenting on the AstraZeneca-Oxford vaccine's results, Adar Poonawalla, CEO, Serum Institute of…